Grafana Labs Brings Faster Full-text Search and Smarter Data Optimization to Grafana Cloud at ObservabilityCON 2026

 SAN FRANCISCO - Wednesday, 21. October 2026 AETOSWire  

Adaptive Logs Archive lets teams keep more logs for less, and faster queries for rare values in Grafana Cloud Logs help them, and their agents, find what matters in seconds

(BUSINESS WIRE) -- Grafana Labs, the company behind the open agentic observability cloud, today announced new releases at ObservabilityCON 2026 that help teams manage their telemetry in the AI era, finding the right log line in seconds and keeping only the telemetry worth paying for as AI workloads scale. Major query performance enhancements to Grafana Cloud Logs, built on technology from the company's Logline acquisition, are now generally available, and Adaptive Logs Archive is in public preview.

AI is massively increasing telemetry volumes. Coding agents are turning everyone into a developer, so more software is being built, faster, and all of it needs to be watched. The agents add to the load too, since every agent call and tool call emits its own telemetry. Left alone, observability costs grow with every new workload, which makes cost and query optimization non-negotiable for running AI at scale. In the 2026 State of Observability Report, also released this week by Grafana Labs and ETR, a Futurum company, 78% of the 300 IT and engineering leaders surveyed increased observability spend last year and 73% expect to again, citing new products added to the stack (61%) and AI-accelerated development creating more to watch (60%).

“The economics of observability only work if you keep the data worth keeping and can dial that up or down as your system’s state changes, and that’s more true than ever with the explosion in telemetry driven by AI,” said Jen Villa, Senior Director of Product, Grafana Labs. “But even the data worth keeping is still massive, so you still need to be able to find what you’re looking for in it, fast. Adaptive Telemetry handles the first, and the query performance enhancements we’ve made in Grafana Cloud Logs handle the second.”

Find the one log line that matters, in seconds

Built on technology from Logline, which Grafana Labs acquired in April 2026, Cloud Logs now offers customers faster full-text search, at no additional cost.

This added functionality identifies logs with low frequency like request IDs and customer IDs over object storage, so an engineer paged at 1 a.m. can find the exact IDs in seconds, straight from the alert. Agents send far more queries than people do, so faster queries let agents and engineers move faster together.

“When I ran our first query on newly submitted logs after enabling Logline, the improvement was clear. We went from processing nearly a terabyte of logs in three minutes to around 100 gigabytes in under three seconds,” said Timo Kirzdörfer, OpenTelemetry & Grafana Cloud Admin, DATEV eG. “That represents an 80–90 percent reduction in the volume of logs searched for newly submitted logs, and we saw the results immediately.”

Keep only the data worth paying for

Grafana Labs’ Adaptive Telemetry suite optimizes cost across metrics, logs, traces, and profiles by recommending what to aggregate or sample, so teams keep the telemetry that matters. The result is better signal at a lower cost: customers using multiple components, including Mux, TeleTracking, and Auditboard, have cut telemetry spend by 30 to 50% on average. New updates cover logs, metrics, and traces:

Adaptive Logs Archive (public preview): Adaptive Logs Archive lets teams route logs to an object storage bucket they own in an open format. They get the cost savings of not putting those logs in Grafana Cloud, but still retaining them in low-cost storage in case they’re ever needed for an investigation, audit, or compliance request.

Adaptive Metrics Auto-Apply (GA): Platform teams no longer have to review cardinality-reduction recommendations one by one. Auto-Apply continuously applies recommendations without a human in the loop, while existing dashboards and alerts keep working unchanged. With Cost Mode, a built-in safeguard only applies recommendations that won’t increase your total active series, so optimization never turns into a cost spike.

Query traces dropped by Adaptive Traces (GA): Sample aggressively without worrying about losing the one trace you need. Developers can retrieve any trace by ID from the last 24 hours, even if Adaptive Traces dropped it, so cost savings never come at the expense of an investigation.

“Before, finding waste meant someone manually digging through metric cardinality and log volume, and the job never ended because new services kept adding more. Adaptive Metrics and Adaptive Logs now do that analysis for us,” said Carl Eastman, Principal Software Engineer, Rapid7. “They show which metrics and log patterns are never queried and recommend what to aggregate or drop, and we apply those recommendations instead of hunting for them. Our engineers spend their time on the few rules that need human judgment, like dropping debug logs we know are noise, rather than the whole long tail.”

Learn more

Check out all the ObservabilityCON announcements on our blog

See the full 2026 State of Observability Report

Read IDC’s The Business Value of Grafana AI report

About Grafana Labs

Grafana Labs is the company behind Grafana Cloud, the fully managed observability platform trusted by more than 10,000 organizations to ensure reliability, resolve incidents faster, and optimize telemetry at scale. Built on open source and open standards and designed for interoperability across any stack, Grafana Cloud brings AI to observability and observability to AI, giving teams (and their agents) unified visibility so they can see, understand, and act on all their disparate data, wherever it lives, and move at the speed of their ambitions. Customers, including Anthropic, Bloomberg, NVIDIA, Microsoft, and Salesforce, rely on Grafana Labs. We are a 100% remote company with team members across 40+ countries, backed by leading investors including Lightspeed Venture Partners, Sequoia Capital, GIC, Coatue, J.P. Morgan, CapitalG, and Lead Edge Capital. Learn more at grafana.com and follow us on LinkedIn and X.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20261020316581/en/

Permalink

https://www.aetoswire.com/en/news/2110202658277

Contacts

Press Contact: press@grafana.com

Merck Collaborates with NVIDIA, Microsoft and Dawn Health to Develop Novel Support Model for People Living with Rare Tumors

 

• Collaboration to explore how AI-facilitated technology can help make patient support programs more individualized, responsive and continuously available to people living with rare tumors
• Collaboration brings together clinical and pharmaceutical expertise, digital health product development, and enterprise AI services
• Merck aims to bring the model to patients with desmoid tumors and neurofibromatosis type 1 with plexiform neurofibromas (NF1-PN)

 (BUSINESS WIRE) -- Merck, a leading science and technology company, today announced a collaboration with NVIDIA Corporation (Santa Clara, California, USA), Microsoft Corporation (Redmond, Washington, USA) and Dawn Health A/S (Copenhagen, Denmark) to build an innovative model for Patient Support Programs (PSPs). The four-way collaboration brings together pharmaceutical and clinical expertise, enterprise technology, AI services and digital health product design, with the shared goal of making specialist-level support more individualized, responsive and continuously available to patients, no matter how complex their treatment journey is.

“Across their treatment journeys, patients with rare tumors often describe challenges that extend well beyond clinical care, like navigating multiple specialists, complex regimens and repeatedly reconstructing their treatment story for each new stakeholder. Our integrated support ecosystem starts with the need. The goal is to truly transform how healthcare is experienced, not add another tool on top of it,” said Miguel Fernández Alcalde, Head of Global Commercial Strategy for Healthcare business sector of Merck. “This solution is designed to make more continuous and personalized support available across small and geographically dispersed rare tumor populations, including patients who may have limited access to specialist care.”

Merck is collaborating on the design of a pioneering integrated support ecosystem tailored to individual needs of people living with rare tumors, their disease state and circumstances. In practice, the outcome is a AI-facilitated companion, available to patients 24/7. Every interaction is grounded in clinically reviewed content, with defined escalation pathways, and full traceability and audit capabilities. Designed to complement, not replace, the care patients receive from their healthcare team, the companion extends the reach and responsiveness of support, while a nurse or healthcare provider remains available when needed. The collaboration builds on and expands a previously announced partnership between Merck and Dawn Health to support rare tumor patients.

Once technical feasibility is confirmed and regulatory requirements are met, the new model will be piloted in key markets in Europe with an initial focus on rare tumors, specifically desmoid tumors and neurofibromatosis type 1 with plexiform neurofibromas (NF1-PN). These disease areas are known to have complex treatment pathways, and high unmet needs of patients, which makes the case for more consistent, higher-quality support particularly urgent.

The multi-way collaboration is grounded on a shared belief that bringing digital interactions, human services and structured data closer together could, over time, help build a more complete view of how a patient's needs evolve throughout their journey.

Three other relevant players in the technology space have key roles in developing this novel patient solution. NVIDIA contributes AI technology & services including NVIDIA Nemotron, NVIDIA Nemotron Reranking open model, NVIDIA NeMo Guardrails, NeMo Relay, NeMo Gym, NeMo Evaluator, NeMo Data Designer to help power the program's performance and safety capabilities; Microsoft provides cloud services (Microsoft Foundry, Azure AI Search, the AI Red Teaming Agent as well as Azure Kubernetes Service, Azure SQL and Azure Monitor to run the Dawn Platform); and Dawn Health leads product development, regulatory experience, and the design of patient-facing applications based on the Dawn Platform offering.

Traditional PSPs have long been a cornerstone of the support pharmaceutical companies offer patients, providing structured, validated guidance throughout the treatment journey. As treatment and care pathways grow more complex, patient demand for support is rising, while the reach of these programs often cannot keep pace. Patients in small or dispersed populations, such as those with rare tumors, continue to have limited access to specialist care.

About Merck's Integrated Health and Medicines

Merck's Integrated Health and Medicines (IHM) brings together medicines, data, devices and human support to better understand patient needs, identify gaps in care, enable better-informed clinical decisions and deliver personalized interventions throughout the patient journey. A medicine marks the start of a patient's support, not the end of it.

Working across Rare Tumors, Specialty, Fertility & Endocrinology, and Cardio-Metabolic care, IHM builds integrated ecosystems, connected devices and decision support tools through its High Touch, High Tech approach: technology helps continuously understand patient needs, anticipate when and where support is required and enable personalized interventions, while healthcare professionals provide the human connection and clinical expertise where they add the greatest value.

Every solution is created with insights from patients, clinicians, and partners who will use it. In the U.S., for example, the company recently launched TGCT & Me, a free app built with insights from patients, healthcare professionals, and a patient advocacy group to help people navigate life with tenosynovial giant cell tumor (TGCT).

About Merck

Merck, a leading science and technology company, operates across life science, healthcare and electronics. More than 62,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2025, Merck generated sales of € 21.1 billion in 65 countries.

Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as MilliporeSigma in life science, EMD Serono in healthcare, and EMD Electronics in electronics.

All Merck press releases are distributed by e-mail at the same time they become available on the Merck website. Please go to www.merckgroup.com/subscribe to register online, change your selection or discontinue this service.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20261020304233/en/

Permalink

https://www.aetoswire.com/en/news/2110202658321

Contacts

Media Relations

gangolf.schrimpf@merckgroup.com

Phone: +49 151 1454 9591

New TOURISE and LIONS Advisory Study Reveals How Creativity Creates a Commercial Advantage for Destination Growth

RIYADH, Saudi Arabia - Wednesday, 21. October 2026

50% of travelers cannot remember the last advertisement they saw for a tourism company or destination, with a further 7% unsure

Tourism faces an $11 billion marketing investment gap: restoring the category’s share of voice to 3% would require global travel and transport ad spend to reach $43.4 billion by 2027

63% of Large Language Model (LLM) visibility is driven by long-term brand equity, compared with 22% from current marketing activity and 11% from citation volume

 

(BUSINESS WIRE)--TOURISE, the world’s premier platform for shaping the future of global tourism, today released IDEAS That Travel, a new report developed in collaboration with LIONS Advisory. The study finds that while travel demand is rising, tourism brands are competing for attention in a more fragmented, socially driven and AI-mediated environment, where visibility alone is no longer enough to secure preference and growth.

“Travelers are discovering destinations earlier and through more channels than ever, from social feeds and creators to communities and AI tools. That raises the bar for tourism brands. Creativity, distinctiveness and trust are becoming central to how destinations earn attention, build preference and remain relevant across the entire traveler journey,” said His Excellency Ahmed Al Khateeb, Minister of Tourism of Saudi Arabia and Chairman of TOURISE.

IDEAS That Travel draws on an online survey of 8,374 consumers across 13 markets who had traveled internationally in the previous 12 months, conducted in December 2025, alongside in-depth interviews with global industry leaders and analysis of LIONS’ marketing research and case studies.

Interviewees include Tony Fernandes, CEO of Capital A and Co-Founder of AirAsia; David Droga, Vice Chair of Accenture; Gonzalo Brujó, CEO and Global Chairman of Interbrand; and Joanne Chehab, Head of MENA Global Business Solutions at ByteDance / TikTok.

The opportunity is significant, but so is the competition. Thirty-nine percent of travelers expect to travel more in the next 12 months than they did in 2025, rising to 51% of Gen Z and 47% of Millennials. Yet tourism marketing is struggling to stay memorable and distinctive: 60% of travelers say travel ads look similar, 43% find it hard to distinguish between travel brands, and 50% cannot remember the last tourism advertisement they saw, with a further 7% unsure.

At the same time, 55% of travelers already use AI in holiday planning and 62% expect to use it more often over the next year. The report argues that future growth will depend on brands building relevance before travelers enter the booking funnel, and doing so consistently across human and AI-led discovery.

“Creativity is a commercial advantage,” said Paul Coxhill, Chief Operating Officer & President, LIONS. “Numerous empirical studies evidence creativity’s role in business growth. The tourism sector is fertile ground for creative effectiveness. Few categories deal so directly in emotion, experience, and memory. Yet in recent years, the sector has seen massive shifts in how people discover, book, and engage with destinations. While demand is rising, so is competition and complexity.”

The report also identifies a widening visibility challenge. Global travel and transport advertising spend rebounded to an estimated $32.4 billion in 2025, but the category’s share of voice remains below pre-pandemic levels. Restoring it to 3% would require investment to reach $43.4 billion by 2027, an $11 billion increase in two years. The report stresses that the answer is not simply more spend, but smarter investment in the social, creator, video and entertainment-led environments where travel intent increasingly forms.

Against this backdrop, IDEAS That Travel sets out a practical framework for tourism brands built around five drivers of effectiveness: Investment, Distinctiveness, Engagement, Authenticity and Seamlessness. Together, they are designed to help brands build visibility, create memorable associations, earn attention through storytelling, strengthen trust through credible experiences, and connect the customer journey across physical and digital touchpoints.

Case studies from Airbnb, Tourism Australia, Visit Sweden, Visit North Carolina and Southwest Airlines show how the principles can be applied in practice. The report concludes that the tourism brands best positioned for future growth will compete not only for bookings, but for attention and cultural relevance, connecting storytelling, creators, AI, media and the lived experience into one coherent system.

The full report is available now at TOURISE.com.

About TOURISE

TOURISE is the world’s premier platform for redefining and shaping the future of tourism.

Powered by the Saudi Ministry of Tourism, the inaugural TOURISE Summit took place 11-13, November 2025 in Riyadh. TOURISE convened visionaries from government, business, investment, tourism and technology communities to deliver high impact initiatives and transformative deals that will reset the industry and build a tourism sector that is sustainable, equitable, and future-focused.

A year-round platform, TOURISE brings together leaders who share a vision to shape the traveler economy. This is where the next 50 years of tourism are shaped.

For more information about TOURISE, visit www.TOURISE.com.

About LIONS Advisory

LIONS Advisory is the consultancy practice of LIONS, helping ambitious marketing leaders establish marketing as a business growth engine through research, benchmarking, strategy and creative effectiveness. LIONS is part of Informa plc.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20261021160141/en/

Permalink

https://www.aetoswire.com/en/news/54626324

Contacts

For further details contact: media@TOURISE.com

Andersen Global Expands Legal Capabilities in Argentina Through Collaboration with MHR

 SAN FRANCISCO - Wednesday, 21. October 2026 AETOSWire Print 

(BUSINESS WIRE) -- Andersen Global strengthens its legal capabilities in Argentina through a Collaboration Agreement with Martínez de Hoz & Rueda (MHR), following the integration of the MBP Partners team into the firm. MBP Partners was previously a collaborating firm of Andersen Global, working alongside the member and collaborating firms of the organization to support clients with local and cross-border matters. With the integration of MBP Partners, the new Collaboration Agreement between Andersen Global and MHR extends that established relationship while strengthening Andersen Global’s legal capabilities in Argentina.

MHR is a full-service law firm, advising clients across oil and gas, corporate and financial matters, energy, mining, fintech, infrastructure, technology, and other key industries. The firm supports domestic and international companies, financial institutions, investment funds, fintechs and other organizations on complex transactions, regulatory matters, and strategic business issues.

“Incorporating the MBP Partners team strengthens our ability to advise clients on increasingly complex transactions and business matters,” said José A. Martínez de Hoz, managing director of MHR. “MBP Partners has already developed strong relationships across the Andersen platform, and we look forward to building on that foundation. Our collaboration connects MHR’s capabilities with global resources to support clients as their businesses expand across jurisdictions.”

“We are pleased to see the MBP Partners team join MHR and look forward to building on our working relationship as MHR joins as a collaborating firm,” said Mark L. Vorsatz, global chairman and CEO of Andersen. “Argentina continues to present significant opportunities for companies navigating investment, infrastructure, and cross-border growth, and MHR’s addition will provide broader support to clients pursuing transactions, investments, and growth opportunities across the region.”

Andersen Global is an international association of legally separate, independent member firms comprised of tax, legal, and valuation professionals around the world. Established in 2013 by U.S. member firm Andersen Tax LLC, Andersen Global now has more than 50,000 professionals worldwide and a presence in over 1,000 locations through its member firms and collaborating firms.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20261021793760/en/

Permalink

https://www.aetoswire.com/en/news/2110202658323

Contacts

Megan Tsuei

Andersen Global

415-764-2700

LTM Launches BlueVerse™ ValueMesh™ to Help Enterprises Scale AI Across Oracle Transformations

MUMBAI, India - 

(BUSINESS WIRE)--LTM, the Business Creativity partner to the world’s largest enterprises, today announced the launch of BlueVerse™ ValueMesh™, an AI execution fabric designed to help enterprises industrialize AI across the Oracle transformation lifecycle, from strategy and implementation to operations and continuous innovation. BlueVerse™ ValueMesh™ is developed and validated by LTM as part of its Cloud Services expertise.

Built on LTM's deep Oracle expertise and BlueVerse™ portfolio, BlueVerse™ ValueMesh™ is designed to help enterprises industrialize AI across their Oracle transformation journey. It brings together AI-native delivery, intelligent automation, AI agents, managed services, intelligent business processes, industry solutions, data, and governance in a unified execution model designed to help organizations move beyond fragmented initiatives and isolated pilots and pursue scalable innovation, continuous optimization, and measurable business outcomes across their Oracle estate.

At its core, BlueVerse™ ValueMesh™ brings together three complementary AI layers:

Enterprise AI applies intelligence across Oracle transformation, software engineering, testing, application management, and cloud operations to help accelerate delivery and improve operational efficiency.

Business AI embeds intelligent agents into enterprise functions such as finance, supply chain, human resources, and customer experience to automate workflows, augment decision-making, and support improved business outcomes.

Industrial AI extends intelligence beyond enterprise applications into assets, field operations, and industry-specific workflows.

BlueVerse™ ValueMesh™ is powered by LTM’s growing portfolio of Business AI agents, AI-led delivery accelerators, industry solutions, and data management and governance capabilities. Its 4S framework—Sense, Shape, Stand Up, and Sustain— provides a structured approach to identifying AI opportunities, designing AI-enabled solutions, deploying them at scale, and continuously optimizing performance.

“As Oracle customers move beyond experimentation, they need a partner that can translate technology investments into sustained business value. Combining LTM’s decades of transformation expertise and proven delivery capabilities across the Oracle ecosystem, BlueVerse™ ValueMesh™ brings together AI-powered delivery, intelligent business processes, industry solutions, and managed services to help enterprises accelerate AI adoption, realize faster time-to-value, and optimize and innovate across their Oracle landscape,” said Krishnan Iyer, Chief Growth Officer, LTM.

To learn more about BlueVerse™ ValueMesh™, click here or visit the LTM booth 5020 at Oracle AI World 2026 in Las Vegas.

About LTM

LTM — a Larsen & Toubro Group Company — is an AI-centric global technology services company and the Business Creativity partner to the world’s largest enterprises. We bring human insights and intelligent systems together to help clients create greater value at the intersection of technology and domain expertise. Our capabilities span integrated operations, transformation, and business AI — enabling new ways of working, new productivity paradigms, and new roads to value. Together with over 87,000 employees across 40 countries and our global network of partners, LTM owns outcomes for our clients, helping them not just outperform the market, but Outcreate it. Read more at LTM.com.

Trademarks

Oracle, Java, MySQL, and NetSuite are registered trademarks of Oracle and/or its affiliates. Other names may be trademarks of their respective owners.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20261020689117/en/

Permalink

https://aetoswire.com/en/news/54626155

Contacts

Media Contact:

Gitanjali Sreepal | Global Media Relations | gitanjali.sreepal@ltm.com

Global Network for the Advancement of Metabolic Psychiatry (MetPsy) Launches with $20 Million Investment in Clinical Care, Education and Research at McLean Hospital

 SAN MATEO, Calif. - Wednesday, 21. October 2026 AETOSWire  

Baszucki Group funding awarded to McLean Hospital to establish a flagship clinical and research center, and jointly to McLean and MH² for medical education and training initiatives

(BUSINESS WIRE) -- Baszucki Group today announced the launch of the Global Network for the Advancement of Metabolic Psychiatry (MetPsy), uniting researchers and clinicians worldwide to advance evidence-based practice in metabolic psychiatry through clinical care, education, and research. The launch is accompanied by a new $20 million grant from Baszucki Group to build a clinical and research center at McLean Hospital, a member of Mass General Brigham, creating the infrastructure to deliver metabolic approaches to psychiatric care at scale. The grant also supports medical education and training initiatives co-led by MH², a clinical practice, training and education hub.

“Over the past five years, metabolic psychiatry has evolved from a few foundational projects into a dynamic, global movement,” said Kirk Nylen, PhD, Executive Director of MetPsy. “Real scientific breakthroughs don’t happen in isolation; they require strong points of connection. MetPsy was created to be that unifying catalyst, bridging scientific and clinical disciplines to translate research into life-changing treatments for people living with severe mental illness. We are proud to launch this global initiative to drive the future of psychiatric care.”

Metabolic psychiatry is the study of how metabolism influences brain function and mental health. While neurologists have used metabolic approaches to treat brain disorders like epilepsy for more than a century, the application of this approach to psychiatric illness is an emerging area of study and practice. Over the past decade, a growing body of research has demonstrated the potential of metabolic treatments such as ketogenic therapy to improve both metabolic health and psychiatric symptoms in serious mental illnesses such as depression, bipolar disorder, and schizophrenia.

As the field expands, demand for resources has grown among researchers and clinicians, as well as the patients they serve. MetPsy addresses this need by providing a centralized network for professional collaboration, shared resources, access to accredited courses, and tools for advancing clinical practice. Backed by foundational support from Baszucki Group, MetPsy aims to include organizations working across all areas of metabolic psychiatry, catalyzing future discoveries and better care.

“The launch of MetPsy reflects our family’s commitment to continuing to advance the field of metabolic psychiatry worldwide,” said Jan Ellison Baszucki, Co-Founder of Baszucki Group. “As this network grows, we hope fellow funders will join us in expanding access to evidence-based metabolic interventions—a clinical approach that has restored the health and future of our son Matthew, and offers that same hope to many more.”

The McLean Center for Metabolic Psychiatry will advance the goals of MetPsy through its core pillars. Dr. Dost Öngür serves as Center Director, overseeing a clinical care center, a research program, and a medical education and training initiative which is co-led by MH² and Dr. Christopher Palmer. Located in Belmont, Massachusetts, McLean Hospital serves as a teaching affiliate for Harvard Medical School and is consistently ranked as the top freestanding psychiatric hospital by U.S. News & World Report.

“Our multidisciplinary team brings together significant clinical and research expertise to expand patient care, offering the first mental healthcare service focused on ketogenic therapy within a larger, established institution,” said Center Director Dost Öngür, MD, PhD, Chief of the Psychotic Disorders Division at McLean Hospital and William P. and Henry B. Test Professor of Psychiatry at Harvard Medical School. “The Center will demonstrate the feasibility of integrated metabolic care and provide an operational blueprint for other academic medical centers worldwide.”

"Advancing emerging approaches to mental health care requires an integrated model that spans research, clinical practice, and specialized medical education. Through this unique model, we are establishing the evidence base and training protocols needed to support multiple dimensions of metabolic psychiatry,” said Christopher M. Palmer, MD, Founder and President of MH², Director of the Metabolic and Mental Health Program at McLean Hospital, and Assistant Professor of Psychiatry at Harvard Medical School.

To learn more about the initiative or join the network, visit metpsy.com. To learn more about the McLean Center for Metabolic Psychiatry, visit the Metabolic Psychiatry Care page.

About Baszucki Group

Launched in 2021 by Roblox founder and Chief Executive Officer David Baszucki and best-selling author Jan Ellison Baszucki, Baszucki Group leverages grantmaking, impact investing, advocacy, storytelling, and community building to drive foundational change in science, medicine, farming, food, and environmental ecosystems. A primary focus of Baszucki Group is supporting initiatives at the intersection of metabolism, psychiatry, and neuroscience with the goal of improving mental health outcomes. For clinicians and researchers interested in learning more about metabolic psychiatry, or in joining the Global Network to Advance Metabolic Psychiatry (MetPsy), visit metpsy.com. To learn more about peer and family resources for metabolic approaches to mental well-being and brain health, visit Metabolic Mind, a nonprofit initiative of Baszucki Group.

About McLean

McLean Hospital has a continuous commitment to put people first in patient care, innovation and discovery, and shared knowledge related to mental health. It is consistently named the #1 freestanding psychiatric hospital in the United States by U.S. News & World Report and is #2 in America for psychiatric care in 2026-27. McLean Hospital is the largest psychiatric affiliate of Harvard Medical School and a member of Mass General Brigham. To stay up to date on McLean, follow us on Facebook, YouTube, and LinkedIn.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20261021217733/en/

Permalink

https://www.aetoswire.com/en/news/2110202658317

Contacts

Media contact: media@baszuckigroup.org

Eight in 10 Professionals Surveyed Say AI Will Boost Restructuring Efficiency, but Execution Gaps Remain

 WILMINGTON, Del. -

82% expect AI to significantly improve restructuring efficiency and decision-making

80% value early governance support, but only 24% involve it at that stage

43% cite role clarity and cross-border SPV administration as the top execution challenges

 

(BUSINESS WIRE) -- More than eight in 10 (82%) restructuring professionals expect AI to significantly improve efficiency and decision-making. At the same time, operational readiness and experienced human judgment will remain critical to successful execution. This is according to new research from CSC, the leading provider of global business administration and compliance solutions.

CSC surveyed 210 professionals globally across banking and financial services, restructuring and turnaround consulting, legal services, and private credit to examine the operational factors shaping restructuring execution1. The findings are detailed in CSC’s guide The Restructuring Execution Gap—Why operational readiness determines outcomes.

Respondents see the clearest potential applications in information gathering, KYC mapping, communications, administration, and monitoring—areas where AI could help reduce friction and accelerate processes rather than replace professional expertise.

However, the optimism around AI has a complex backdrop, with execution risk spread across several interconnected operational challenges rather than one single bottleneck. Clarifying roles and responsibilities and administering SPVs or restructuring vehicles efficiently across jurisdictions are joint leading challenges, each cited by 43% of respondents. Managing cross-border complexity and time zones follows closely at 42%, while 39% point to the speed of onboarding or appointment, including AML/KYC.

“AI has the potential to support decision making and streamline some of the behind the scenes work that goes into the restructuring process. But technology works best when it complements experienced professional judgment. The real opportunity is in combining the right tools with people who understand the complexities of restructuring and know how to apply them effectively,” says Sean Foronjy, director, Corporate Trust and Agency, CSC,

The research also points to a timing issue: operational support is not always brought into a restructuring as early as professionals believe it would be valuable. While 80% consider governance services very or quite valuable at the early stage, only 24% say those services were first involved then. The same pattern appears for SPV and entity services, at 67% versus 25%, and corporate trust and agency services, at 56% versus 15%.

The findings also show strong demand for integrated and experienced restructuring support.

Jordina Walker, head of Restructuring and Special Situations EMEA, CSC, adds, “Commercial decisions can take months, but once parties know what they want to do, they want to move very fast. At that point, the question becomes less about whether a restructuring route is viable and more about how quickly the necessary entities, appointments, documentation, and support can be put in place.”

An overwhelming majority (83%) of respondents rate the ability to provide governance and director services, SPV administration, and trust and agency capabilities in one place as important, while 77% say the same about demonstrated restructuring and distressed-situation experience. The findings underline that, as restructurings become more complex and cross-border, execution readiness increasingly depends on having the right expertise, infrastructure and support in place before timelines become compressed.

Frequently asked questions about restructuring execution and operational readiness

How could AI improve corporate restructuring?

Eighty-two percent of restructuring professionals expect AI to significantly improve efficiency and decision-making, particularly in information gathering, KYC mapping, communications, administration, and monitoring.

What are the biggest operational challenges in restructuring?

Clarifying roles and responsibilities and administering SPVs or restructuring vehicles across jurisdictions are the joint leading challenges, each cited by 43% of respondents.

When should operational support be involved in a restructuring?

Eighty percent consider governance services valuable at the early stage, but only 24% say those services were first involved then.

Download CSC’s guide, The Restructuring Execution Gap—Why operational readiness determines outcomes.

About CSC

CSC is the leading provider of business administration and compliance solutions, offering industry-leading expertise and unmatched global reach to alternative fund managers and capital markets participants. Leveraging deep institutional experience and a tailored approach, CSC delivers a comprehensive suite of fund administration, trust, agency, and compliance services to support a wide range of private and public market transactions, complex fund strategies, and scalable operations.

As the trusted partner of choice for more than 75% of the PEI 300 and 90% of the Fortune 500®, CSC helps clients navigate operational and transactional complexities across more than 140 jurisdictions and various asset classes. With extensive worldwide capabilities, our expert teams provide solutions tailored to each client’s needs. Privately held and professionally managed since 1899, we combine global reach, local expertise, and innovative solutions to help our clients succeed.

We are the business behind business®. Learn more at cscglobal.com.

____________________

1CSC surveyed 210 full-time professionals globally across banking and financial services; restructuring, turnaround, and financial advisory consulting; law and legal services; and private credit or private debt. All respondents were involved in corporate restructuring or distressed financing during the past three years. Survey respondents are equally weighted across Asia Pacific, Europe including the U.K., and the Americas.

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20261020382702/en/

Permalink

https://www.aetoswire.com/en/news/2010202658255

Contacts

For more information:

CDR Consultancy

Amber Liu | Hassan Ali

csc@cdrconsultancy.com

CSC

Katie Scott-Kurti

Head of Brand and Communications | Marketing

katie.scottkurti@cscglobal.com

CSC News Room